The elevating incidences of prolonged exposure to lung irritants like air pollutants and tobacco smoke, which damage the lungs by causing inflammation as well as narrowing of the airways, are primarily augmenting the chronic obstructive pulmonary disease market.

1. Chronic Obstructive
Pulmonary Disease
Market Research
Report 2023-2033

2. ABOUT IMARC
2
International Market Analysis Research and Consulting Group is a
leading adviser on management strategy and market research
worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their
most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific,
economic and technological developments for business leaders in
pharmaceutical, industrial, and high technology organizations.
Market forecasts and industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel and tourism,
nanotechnology and novel processing methods are at the top of
the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into
the dynamics of companies and markets with close cooperation at
all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient
organizations, and secure lasting results.

3. Report Description and Highlights
Chronic Obstructive Pulmonary Disease Market 2023-2033
IMARC Group has recently released a report titled “Chronic Obstructive Pulmonary Disease Market: Analysis of Epidemiology, Industry Trends,
Size, Share, and Future Forecast (2023-2033)” that presents a comprehensive assessment of the chronic obstructive pulmonary disease market
report, latest trends, and growth forecast. The report provides an extensive overview of the latest market trends, growth prospects, investment
opportunities, and industry outlook, as well as an in-depth analysis of the disease landscape, market scenario, and growth trends. Furthermore,
the report offers an analysis of competitors, regional markets, and recent advancements in the global market. It also sheds light on crucial
segments and market drivers, along with challenges faced by industry players. This report is a valuable resource for stakeholders who want to
gain valuable insights into the chronic obstructive pulmonary disease market.
Chronic obstructive pulmonary disease (COPD) represents a chronic respiratory disorder characterized by persistent airflow limitation owing to
the inflammation of the airways and the destruction of lung tissue. Some of the common symptoms of the ailment include chest tightness,
chronic cough, excess mucus production, shortness of breath, wheezing, etc. COPD can also cause weight loss, depression, and other systemic
effects. The diagnosis of the condition typically involves a combination of medical history, physical examination, lung function tests, and imaging
studies. 3

4. Report Description and Highlights
Chronic Obstructive Pulmonary Disease Market Trend:
The elevating incidences of prolonged exposure to lung irritants like air pollutants and tobacco smoke, which damage the lungs by causing
inflammation as well as narrowing of the airways, are primarily augmenting the chronic obstructive pulmonary disease market.
Additionally, the increasing prevalence of various associated risk factors, including genetic predisposition, exposure to chemical fumes, and
certain respiratory infections, like pneumonia and bronchitis, is further stimulating the market growth. Besides this, the growing adoption
of numerous medications, such as phosphodiesterase-4 inhibitors, bronchodilators, corticosteroids, etc., to open the airways, minimize
inflammation, and enhance lung functioning is acting as another significant growth-inducing factor.
Furthermore, the rising utilization of lung volume reduction surgery (LVRS) for treating selected patients with severe COPD is also
contributing to the market growth. Apart from this, the emerging popularity of non-invasive ventilation for enhancing breathing and
oxygenation without requiring invasive procedures like intubation or mechanical ventilation in patients is projected to catalyze the chronic
obstructive pulmonary disease market over the forecasted period.
Request a Sample Report: https://www.imarcgroup.com/chronic-obstructive-pulmonary-disease-market/requestsample
4

5. Report Description and Highlights
What is included in the report segmentation?
The report covers the following aspects:
Report Period:
• Base Year: 2022
• Historical Period: 2017-2022
• Market Forecast: 2023-2033
Countries Included:
• United States
• Germany
• France
5

6. Report Description and Highlights
• United Kingdom
• Italy
• Spain
• Japan
Analysis Covered Across Each Country
• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the Chronic Obstructive Pulmonary Disease market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the Chronic Obstructive Pulmonary Disease market
• Reimbursement scenario in the market
• In-market and pipeline drugs
6

7. Report Description and Highlights
In-Market Drugs
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Regulatory Status
View Report TOC, Figures and Tables: https://www.imarcgroup.com/chronic-obstructive-pulmonary-disease-market
7

8. Key Questions Answered in the Report
1. How has the Chronic Obstructive Pulmonary Disease Market performed so far and how will it perform in the coming years?
2. What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
3. What was the country-wise size of the Chronic Obstructive Pulmonary Disease Market across the seven major markets in 2022 and
what will it look like in 2033?
4. What is the growth rate of the Chronic Obstructive Pulmonary Disease Market across the seven major markets and what will be the
expected growth over the next ten years?
5. What are the key unmet needs in the market?
8

9. Table of
Contents

10. Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
10

11. Table of Contents
4 Chronic Obstructive Pulmonary Disease - Introduction
4.1 Overview
4.2 Regulatory Process
4.3 Epidemiology (2017-2022) and Forecast (2023-2033)
4.4 Market Overview (2017-2022) and Forecast (2023-2033)
4.5 Competitive Intelligence
5 Chronic Obstructive Pulmonary Disease - Disease Overview
5.1 Introduction
5.2 Symptoms and Diagnosis
5.3 Pathophysiology
5.4 Causes and Risk Factors
5.5 Treatment
Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/chronic-obstructive-
pulmonary-disease-market/toc
11

12. Partial List Of Our Clients
12

13. OUR CLIENTS
13

14. Disclaimer
14
© 2023 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis
Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or
in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including
photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information
and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting
makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts
no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and
Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.